Cargando…

A chromatographic approach to development of 5-aminosalicylate/folic acid fixed-dose combinations for treatment of Crohn’s disease and ulcerative colitis

Medication adherence is an important factor in inflammatory bowel disease therapy, which includes regular supplementation of malabsorbed vitamins. Absorption of folic acid is limited due to the damaging of the gastrointestinal tract, which can increase the chances to develop megaloblastic anaemia an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeličić, Mario-Livio, Brusač, Edvin, Klarić, Daniela Amidžić, Nigović, Biljana, Turk, Nikša, Mornar, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705649/ https://www.ncbi.nlm.nih.gov/pubmed/33257796 http://dx.doi.org/10.1038/s41598-020-77654-2

Ejemplares similares

Pharmacokinetic Profiling and Simultaneous Determination of Thiopurine Immunosuppressants and Folic Acid by Chromatographic Methods
por: Brusač, Edvin, et al.
Publicado: (2019)

Physicochemical Compatibility Investigation of Mesalazine and Folic Acid Using Chromatographic and Thermoanalytical Techniques
por: Jeličić, Mario-Livio, et al.
Publicado: (2020)

A Comprehensive Approach to Compatibility Testing Using Chromatographic, Thermal and Spectroscopic Techniques: Evaluation of Potential for a Monolayer Fixed-Dose Combination of 6-Mercaptopurine and Folic Acid
por: Brusač, Edvin, et al.
Publicado: (2021)

Drug–Drug Compatibility Evaluation of Sulfasalazine and Folic Acid for Fixed-Dose Combination Development Using Various Analytical Tools
por: Jeličić, Mario-Livio, et al.
Publicado: (2021)

Determination of Curcuminoids, Piperine, Boswellic Acids and Andrographolides in Food and Dietary Supplements by HPLC
por: Brusač, Edvin, et al.
Publicado: (2022)

Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease
por: Jeličić, Mario-Livio, et al.
Publicado: (2022)

Antioxidant Activity of Pharmaceuticals: Predictive QSAR Modeling for Potential Therapeutic Strategy
por: Jeličić, Mario-Livio, et al.
Publicado: (2022)

Assessment of Physicochemical Parameters and Contaminants in Herbal Dietary Supplements Used in the Treatment of Inflammatory Bowel Disease
por: Amidžić Klarić, Daniela, et al.
Publicado: (2023)

Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis
por: Tripathi, Kartikeya, et al.
Publicado: (2021)

5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
por: Miyoshi, Jun, et al.
Publicado: (2018)

Assessment of Bioactive Phenolic Compounds and Antioxidant Activity of Blackberry Wines
por: Amidžić Klarić, Daniela, et al.
Publicado: (2020)

Post-Flood Impacts on Occurrence and Distribution of Mycotoxin-Producing Aspergilli from the Sections Circumdati, Flavi, and Nigri in Indoor Environment
por: Jakšić, Daniela, et al.
Publicado: (2020)

Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates
por: Freeman, Hugh James
Publicado: (2012)

The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis
por: He, Long, et al.
Publicado: (2021)

Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis
por: Mikami, Yohei, et al.
Publicado: (2023)

5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis
por: Xu, Jun, et al.
Publicado: (2018)

Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis
por: Yan, Yan, et al.
Publicado: (2019)

Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis
por: Lee, Jin, et al.
Publicado: (2019)

Colon-targeting mutual prodrugs of 5-aminosalicylic acid and butyrate for the treatment of ulcerative colitis
por: Yan, Yan, et al.
Publicado: (2018)

Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis
por: Park, Soo-Kyung, et al.
Publicado: (2022)

Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
por: Sood, Ajit, et al.
Publicado: (2020)

5-Aminosalicylates Reduce the Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis: An Updated Meta-Analysis
por: Zhao, Li-Na, et al.
Publicado: (2014)

A New Chinese Medicine Intestine Formula Greatly Improves the Effect of Aminosalicylate on Ulcerative Colitis
por: Liu, Baohai, et al.
Publicado: (2017)

Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis
por: Uchiyama, Kazuhiko, et al.
Publicado: (2023)

Identification and Quantification of Flavonoids and Phenolic Acids in Burr Parsley (Caucalis platycarpos L.), Using High-Performance Liquid Chromatography with Diode Array Detection and Electrospray Ionization Mass Spectrometry
por: Plazonić, Ana, et al.
Publicado: (2009)

Ulcerative Colitis Impairs the Acylethanolamide-Based Anti-Inflammatory System Reversal by 5-Aminosalicylic Acid and Glucocorticoids
por: Suárez, Juan, et al.
Publicado: (2012)

Combination of Azathioprine and Aminosalicylate Treatment Prevent Risk of Cardiovascular Disease in Women with Ulcerative Colitis by Reducing Inflammation
por: dos Santos, Lana Claudinez, et al.
Publicado: (2015)

Comparison of maintenance effect of probiotics and aminosalicylates on ulcerative colitis: A meta-analysis of randomized controlled trials
por: Jiang, Yong, et al.
Publicado: (2016)

Mucosal 5‐aminosalicylic acid concentration, drug formulation and mucosal microbiome in patients with quiescent ulcerative colitis
por: Olaisen, Maya, et al.
Publicado: (2019)

Therapeutic Efficacy of the Combination Therapy of Corticosteroids and 5-Aminosalicylic Acid for Treatment of Pyoderma Gangrenosum with Ulcerative Colitis
por: Chen, Wei, et al.
Publicado: (2020)

Comparison of effects of aminosalicylic acid, glucocorticoids and immunosuppressive agents on the expression of multidrug-resistant genes in ulcerative colitis
por: Chen, Yan, et al.
Publicado: (2022)

Fecal microbiota transplantation treatment for refractory ulcerative colitis with allergy to 5-aminosalicylic acid: A case report
por: Wang, Hong-Gang, et al.
Publicado: (2018)

Probiotics combined with aminosalicylic acid affiliates remission of ulcerative colitis: a meta-analysis of randomized controlled trial
por: Peng, Lijun, et al.
Publicado: (2019)

5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis
por: Mizuno, Shinta, et al.
Publicado: (2020)

Mucosal concentrations of N‐acetyl‐5‐aminosalicylic acid related to endoscopic activity in ulcerative colitis patients with mesalamine
por: Fukuda, Tomohiro, et al.
Publicado: (2020)

Efficacy and safety of Kangfuxin liquid combined with aminosalicylic acid for the treatment of ulcerative colitis: A systematic review and meta-analysis
por: Li, Hui-biao, et al.
Publicado: (2018)

Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remission phase
por: Madarame, Akira, et al.
Publicado: (2021)

Factors associated with the persistence of oral 5-aminosalicylic acid monotherapy in ulcerative colitis: a nationwide Norwegian cohort study
por: Fossmark, Reidar, et al.
Publicado: (2021)

Crohn's disease and ulcerative colitis Surgical management
por: Wilkinson, A J
Publicado: (1996)

Mucosal Barrier in Ulcerative Colitis and Crohn's Disease
por: Dorofeyev, A. E., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k1vfsqtorhmo9b8esbtcbcfc0s